This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Retatrutide: a triple incretin receptor agonist for obesity management.
Expert opinion on investigational drugs, 32(11), 1003-1008
Citation
Ray, Avik. (2023). Retatrutide: a triple incretin receptor agonist for obesity management.. Expert opinion on investigational drugs, 32(11), 1003-1008. https://doi.org/10.1080/13543784.2023.2276754